Marked decrease of LSD-induced stimulus control in serotonin transporter knockout mice

Pharmacology Biochemistry and Behavior

Volumn 88, Issue 3, 2008, Pages 349-357

  Krall, C M ^a   Richards, J B ^b   Rabin, R A ^a   Winter, J C ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b RESEARCH INSTITUTE ON ADDICTIONS   (United States)

Author keywords

Drug discrimination; Knockout; Lysergic acid diethylamide (LSD); Mouse; Pentobarbital; Serotonin transporter; SERT

Indexed keywords

LYSERGIDE; PHENOBARBITAL; SEROTONIN TRANSPORTER;

ARTICLE; CONTROLLED STUDY; DRUG DISCRIMINATION; DRUG MECHANISM; DRUG RESPONSE; GENOTYPE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STIMULUS RESPONSE; VISUAL STIMULATION;

ANIMALS; CONDITIONING, OPERANT; DISCRIMINATION LEARNING; GABA MODULATORS; GENOTYPE; HALLUCINOGENS; HYPNOTICS AND SEDATIVES; LIGHT; LYSERGIC ACID DIETHYLAMIDE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PENTOBARBITAL; REINFORCEMENT SCHEDULE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

ANIMALIA; MUS; RATTUS;

EID: 36148985691     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2007.09.006     Document Type: Article

References (81)

1. Adamec R., Burton P., Blundell J., Murphy D.L., and Holmes A. Vulnerability to mild predator stress in serotonin transporter knockout mice. Behav Brain Res 170 (2006) 126-140
2. Anden N.E., Dahlström A., Fuxe K., and Larsson K. Mapping out of catecholamine and 5-hydroxytryptamine neurons innervating the telencephalon and diencephalon. Life Sci 4 (1965) 1275-1279
3. Ansorge M.S., Zhou M., Lira A., Hene R., and Gingrich J.A. Early-life blockade of the 5-HT transporter alters emotional behavior in adult mice. Science 306 (2004) 879-881
4. Balster R.L., and Moser V.C. Pentobarbital discrimination in the mouse. Alcohol Drug Res 7 (1987) 233-242
5. Bengel D., Murphy D.L., Andrews A.M., Wichems C.H., Feltner D., Heils A., et al. Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymethamphatamine ("ecstasy") in serotonin transporter-deficient mice. Mol Pharmacol 53 (1998) 649-655
6. Benneyworth M.A., Smith R.L., Barrett R.J., and Sanders-Bush E. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. Psychopharmacology (Berl) 179 (2005) 854-862
7. Borlongan C.V., and Watanabe S. Footshock facilitates discrimination of stimulus properties of morphine. Life Sci 61 (1997) 1045-1049
8. 1A autoreceptors in knockout mice deficient in the 5-HT transporter. Eur J Neurosci 18 (2003) 2203-2212
9. Boyce-Rustay J.M., Wiedholz L.M., Millstein R.A., Carroll J., Murphy D.L., Daws L.C., et al. Ethanol-related behaviors in serotonin transporter knockout mice. Alcohol Clin Exp Res 30 (2006) 1957-1965
10. Brauer L.H., Goudie A.J., and deWit H. Dopamine ligands and the stimulus effects of amphetamine: animal models versus human laboratory data. Psychopharmacology (Berl) 130 (1997) 2-13
11. Bucan M., and Abel T. The mouse: genetics meets behavior. Nat Rev Genet 3 (2002) 114-123
12. Cunningham K.A., and Appel J.B. Neuropharmacological reassessment of the discriminative stimulus properties of d-lysergic acid diethylamide (LSD). Psychopharmacology (Berl) 91 (1987) 67-73
13. Dahlström A., and Fuxe K. Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brainstem neurons. Acta Physiol Scand 62 suppl 232 (1964) 1-55
14. Dykstra L.A., Preston K.L., and Bigelow G.E. Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects. Psychopharmacology (Berl) 130 (1997) 14-27
15. 2C receptor-mediated interaction between 2,5-dimethoxy-4-methylamphetamine and citalopram in the rat. Pharmacol Biochem Behav 79 (2004) 25-30
16. Esaki T., Cook M., Shimoji K., Murphy D.L., Sokoloff L., and Holmes A. Developmental disruption of serotonin transporter function impairs cerebral responses to whisker stimulation in mice. Proc Natl Acad Sci U S A 102 (2005) 5582-5587
17. 1B receptors in knock-out mice lacking the 5-HT transporter. Eur J Neurosci 12 (2000) 2299-2310
18. 2C receptors in the stimulus effects of hallucinogenic drugs. I: antagonist correlation analysis. Psychopharmacology (Berl) 121 (1995) 347-356
19. 2C receptors in the stimulus effects of hallucinogenic drugs. III: the mechanistic basis for supersensitivity to the LSD stimulus following serotonin depletion. Psychopharmacology (Berl) 121 (1995) 364-372
20. 1A receptor antagonist, WAY-100635. Eur J Pharmacol 281 (1995) 81-88
21. Geter-Douglass B., and Witkin J.M. Behavioral effects and anticonvulsant efficacies of low-affinity, uncompetitive NMDA antagonists in mice. Psychopharmacology (Berl) 146 (1999) 280-289
22. Gingrich J.A., and Hen R. Dissecting the role of the serotonin system in neuropsychiatric disorders using knockout mice. Psychopharmacology (Berl) 155 (2001) 1-10
23. Glennon R.A., Rosecrans J.A., and Young R. The use of the drug discrimination paradigm for studying hallucinogenic agents. In: Colpaert F.C., and Slangen J.L. (Eds). Drug discrimination: applications in CNS pharmacology (1982), Elsevier, Amsterdam 69-96
24. Gobbi G., Murphy D.L., Lesch K.P., and Blier P. Modifications of the serotonergic system in mice lacking serotonin transporters: an in vivo electrophysiological study. J Pharmacol Exp Ther 296 (2001) 987-995
25. Gommans J., Bouwknecht J.A., Hijzen T.H., Berendsen H.H., Broekkamp C.L., Maes R.A., et al. Stimulus properties of fluvoxamine in a conditioned taste aversion procedure. Psychopharmacology 140 (1998) 496-502
26. González-Maeso J., Yuen T., Ebersole B.J., Wurmbach E., Lira A., Zhou M., et al. Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonists effects in mouse somatosensory cortex. J Neurosci 23 (2003) 8836-8843
27. 2A receptor-mediated signaling pathways to affect behavior. Neuron 53 (2007) 439-452
28. Grant K.A., Knisely J.S., Tabakoff B., Barrett J.E., and Balster R.L. Ethanol-like discriminative stimulus effects of non-competitive NMDA antagonists. Behav Pharmacol 2 (1991) 87-95
29. Grilly D.M. Effects of prior experience on differential learning under amphetamine. Psychopharmacologia 43 (1975) 271-277
30. Harris R.T., and Balster R.L. An analysis of the function of drugs in the stimulus control of operant behavior. In: Thompson T., and Pickens R. (Eds). Stimulus properties of drugs (1971), Appleton-Century-Crofts, New York 111-132
31. Hirschhorn I., and Winter J.C. Mescaline and LSD as discriminative stimuli. Psychopharmacologia 22 (1971) 64-71
32. Holmes A., Li Q., Murphy D.L., Gold E., and Crawley J.N. Abnormal anxiety-related behavior in serotonin transporter null mutant mice: the influence of genetic background. Genes Brain Behav 2 (2003) 365-380
33. 1A receptor-mediated abnormalities in tests for anxiety-like behavior. Neuropsychopharmacology 28 (2003) 2077-2088
34. Homberg J.R., Olivier J.D.A., Smits B.M.G., Mul J.D., Mudde J., Verheul M., et al. Characterization of the serotonin transporter knockout rat: a selective change in the functioning of the serotonergic system. Neuroscience 146 (2007) 1662-1676
35. 2A receptor ligand. Naunyn Schmiedebergs Arch Pharmacol 354 (1996) 205-209
36. Kamien J., Bickel W., Hughes J., Higgins S., and Smith B. Drug discrimination by humans compared to nonhumans: current status and future directions. Psychopharmacology (Berl) 111 (1993) 259-270
37. Kelaï S., Aissi F., Lesch K.P., Cohen-Salmon C., Hamon M., and Lanfumey L. Alcohol intake after serotonin transporter inactivation in mice. Alcohol Alcohol 38 (2003) 386-389
38. Kim D.K., Tolliver T.J., Huang S.J., Martin B.J., Andrews A.M., Wichems C., et al. Altered serotonin synthesis, turnover and dynamic regulation in multiple brain regions of mice lacking the serotonin transporter. Neuropharmacology 49 (2005) 798-810
39. A receptor α1 subunit-containing receptors alters responses to ethanol and other anesthetics. J Pharmacol Exp Ther 305 (2003) 600-607
40. 1A binding sites in 5-HT transporter knockout mice. J Pharmacol Exp Ther 291 (1999) 999-1007
41. 1A) in 5-HT transporter knock-out mice: gender and brain region differences. J Neurosci 20 (2000) 7888-7895
42. 2C receptors in serotonin transporter knockout mice. J Neurochem 84 (2003) 1256-1265
43. Lira A., Zhou M., Castanon N., Ansorge M.S., Gordon J.A., Francis J.H., et al. Altered depression-related behaviors and functional changes in the dorsal raphe nucleus of serotonin transporter-deficient mice. Biol Psychiatry 54 (2003) 960-971
44. Mathews T.A., Fedele D.E., Coppelli F.M., Avila A.M., Murphy D.L., and Andrews A.M. Gene dose-dependent alterations in extraneuronal serotonin but not dopamine in mice with reduced serotonin transporter expression. J Neurosci Methods 140 (2004) 169-181
45. Mehta A.K., and Ticku M.K. Interactions of pentobarbital and phenobarbital with GABAergic drugs against chemoconvulsants in rats. Pharmacol Biochem Behav 30 (1988) 995-1000
46. Middaugh L.D., Favara J.P., Boggan W.O., and Stringer A.J. Discriminative properties of phencyclidine in mice: generalization to ketamine and monohydroxy metabolites. Psychopharmacology (Berl) 96 (1988) 381-384
47. Middaugh L.D., McGroarty K.K., Groseclose C.H., and Adinoff B. Cocaine discrimination: relationship to local anesthetics and monoamine uptake inhibitors in C57BL/6 mice. Psychopharmacology (Berl) 136 (1998) 44-49
48. Montañez S., Owens W.A., Gould G.G., Murphy D.L., and Daws L.C. Exaggerated effect of fluvoxamine in heterozygous serotonin transporter knockout mice. J Neurochem 86 (2003) 210-219
49. Oh S., Hoshi K., and Ho I.K. Role of NMDA receptors in pentobarbital tolerance/dependence. Neurochem Res 22 (1997) 767-774
50. Overton D.A. Discriminative control of behavior by drug states. In: Thompson T., and Pickens R. (Eds). Stimulus properties of drugs (1971), Appleton-Century-Crofts, New York 87-110
51. Pan Y., Gembom E., Peng W., Lesch K.P., Mossner R., and Simantov R. Plasticity in serotonin uptake in primary neuronal cultures of serotonin transporter knockout mice. Brain Res Dev Brain Res 126 (2001) 125-129
52. Perez X., and Andrews A.M. Chronoamperometry to determine differential reductions in uptake in brain synaptosomes from serotonin transporter knockout mice. Anal Chem 77 (2005) 818-826
53. Philibin S.D., Prus A.J., Pehrson A.L., and Porter J.H. Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice. Psychopharmacology (Berl) 180 (2005) 49-56
54. 2 and arachidonic acid is attenuated in mice lacking the serotonin reuptake transporter. Psychopharmacology (Berl) 180 (2005) 12-20
55. Rees D.C., and Balster R.L. Attenuation of the discriminative stimulus properties of ethanol and oxazepam, but not of pentobarbital, by Ro 15-4513 in mice. J Pharmacol Exp Ther 244 (1988) 592-598
56. 1A receptor and the stimulus effects of LSD in the rat. Psychopharmacology (Berl) 182 (2005) 197-204
57. 2A receptors in mice lacking the serotonin transporter. Neurosci Lett 262 (1999) 113-116
58. Rumajogee P., Verge D., Hanoun N., Brisorgueil M.J., Hen R., Lesch K.P., et al. Adaption of the serotoninergic neuronal phenotype in the absence of 5-HT autoreceptors or the 5-HT transporter: involvement of BDNF and cAMP. Eur J Neurosci 19 (2004) 937-944
59. Salichon N., Gaspar P., Upton A.L., Picaud S., Hanoun N., Hamon M., et al. Excessive activation of serotonin (5-HT) 1B receptors disrupts the formation of sensory maps in monoamine oxidase a and 5-ht transporter knock-out mice. J Neurosci 21 (2001) 884-896
60. Schreiber R., Brocco M., and Millan M.J. Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. Eur J Pharmacol 264 (1994) 99-102
61. 1A agonists. J Pharmacol Exp Ther 273 (1995) 101-112
62. Seong E., Seasholtz A.F., and Burmeister M. Mouse models of psychiatric disorders. Trends Genet 18 (2002) 643-650
63. Shannon H.E., and Holtzman S.G. Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmacology (Berl) 61 (1979) 239-244
64. Shulgin A.T., and Shulgin A. PiHKAL: a chemical love story (1991), Transform Press, Berkley 633-637
65. Smith R.L., Barrett R.J., and Sanders-Bush E. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(±)DOI] in C57BL/6 J mice. Psychopharmacology (Berl) 166 (2003) 61-68
66. Snoddy A.M., and Tessel R.E. Nisoxetine and amphetamine share discriminative stimulus properties in mice. Pharmacol Biochem Behav 19 (1983) 205-210
67. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., et al. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci U S A 95 (1998) 7699-7704
68. Stolerman I.P., and Kamien J.B. Drug discrimination bibliographic database (2004). http://www.dd-database.org/
69. Trigo J.M., Renoir T., Lanfumey L., Hamon M., Lesch K.P., Robledo P., et al. 3,4-Methylenedioxymethamphetamine self-administration is abolished in serotonin transporter knockout mice. Biol Psychiatry 62 (2007) 669-679
70. Varvel S.A., James J.R., Bowen S., Rosecrans J.A., and Karan L.D. Discriminative stimulus properties of nicotine in the C57BL/6 mouse. Pharmacol Biochem Behav 63 (1999) 27-32
71. Wellman C.L., Izquierdo A., Garrett J.E., Martin K.P., Carroll J., Millstein R., et al. Impaired stress-coping and fear extinction and abnormal corticolimbic morphology in serotonin transporter knock-out mice. J Neurosci 27 (2007) 684-691
72. Wettstein J.G., Host M., and Hitchcock J.M. Selectivity of action of typical and atypical anti-psychotic drugs as antagonists of the behavioral effects of 1-[2,5-dimethoxy-4-iodophenyl]-2-aminopropane (DOI). Prog Neuropsychopharmacol Biol Psychiatry 23 (1999) 533-544
73. Willins D.L., and Meltzer H.Y. Direct injection of 5-HT 2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats. J Pharmacol Exp Ther 282 (1997) 699-706
74. Winter J.C. Hallucinogens as discriminative stimuli. Fed Proc 33 (1974) 1825-1832
75. Winter J.C. Drug-induced stimulus control. In: Blackman D.E., and Sanger D.J. (Eds). Contemporary research in behavioral pharmacology (1978), Plenum Press, New York 209-237
76. Winter J.C., and Rabin R.A. Interactions between serotonergic agonists and antagonists in rats trained with LSD as a discriminative stimulus. Pharmacol Biochem Behav 30 (1987) 617-624
77. 1A receptors. Pharmacol Biochem Behav 65 (2000) 75-82
78. 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli. Psychopharmacology (Berl) 172 (2004) 233-240
79. Winter J.C., Kieres A.K., Zimmerman M.D., Reissig C.J., Eckler J.R., Ullrich T., et al. The stimulus properties of LSD in C57BL/6 mice. Pharmacol Biochem Behav 81 (2005) 830-837
80. Zhou F.C., Lesch K.P., and Murphy D.L. Serotonin uptake into dopamine neurons via dopamine transporters: a compensatory alternative. Brain Res 942 (2002) 109-119
81. Zhuang X., Masson J., Gingrich J.A., Rayport S., and Hen R. Targeted gene expression in dopamine and serotonin neurons of the mouse brain. J Neurosci Methods 143 (2005) 27-32